Discovery of Genetic Variation on Chromosome 5q22 Associated with Mortality in Heart Failure

Failure of the human heart to maintain sufficient output of blood for the demands of the body, heart failure, is a common condition with high mortality even with modern therapeutic alternatives. To identify molecular determinants of mortality in patients with new-onset heart failure, we performed a...

Full description

Bibliographic Details
Main Authors: Wang, Xinchen, Kellis, Manolis, Boyer, Laurie Ann
Other Authors: Massachusetts Institute of Technology. Department of Biology
Format: Article
Language:en_US
Published: Public Library of Science 2017
Online Access:http://hdl.handle.net/1721.1/108114
https://orcid.org/0000-0003-3491-4962
_version_ 1826199870996742144
author Wang, Xinchen
Kellis, Manolis
Boyer, Laurie Ann
author2 Massachusetts Institute of Technology. Department of Biology
author_facet Massachusetts Institute of Technology. Department of Biology
Wang, Xinchen
Kellis, Manolis
Boyer, Laurie Ann
author_sort Wang, Xinchen
collection MIT
description Failure of the human heart to maintain sufficient output of blood for the demands of the body, heart failure, is a common condition with high mortality even with modern therapeutic alternatives. To identify molecular determinants of mortality in patients with new-onset heart failure, we performed a meta-analysis of genome-wide association studies and follow-up genotyping in independent populations. We identified and replicated an association for a genetic variant on chromosome 5q22 with 36% increased risk of death in subjects with heart failure (rs9885413, P = 2.7x10⁻⁹. We provide evidence from reporter gene assays, computational predictions and epigenomic marks that this polymorphism increases activity of an enhancer region active in multiple human tissues. The polymorphism was further reproducibly associated with a DNA methylation signature in whole blood (P = 4.5x10⁻⁴⁰) that also associated with allergic sensitization and expression in blood of the cytokine TSLP (P = 1.1x10⁻⁴). Knockdown of the transcription factor predicted to bind the enhancer region (NHLH1) in a human cell line (HEK293) expressing NHLH1 resulted in lower TSLP expression. In addition, we observed evidence of recent positive selection acting on the risk allele in populations of African descent. Our findings provide novel genetic leads to factors that influence mortality in patients with heart failure.
first_indexed 2024-09-23T11:27:08Z
format Article
id mit-1721.1/108114
institution Massachusetts Institute of Technology
language en_US
last_indexed 2024-09-23T11:27:08Z
publishDate 2017
publisher Public Library of Science
record_format dspace
spelling mit-1721.1/1081142022-10-01T03:44:20Z Discovery of Genetic Variation on Chromosome 5q22 Associated with Mortality in Heart Failure Wang, Xinchen Kellis, Manolis Boyer, Laurie Ann Massachusetts Institute of Technology. Department of Biology Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science Wang, Xinchen Kellis, Manolis Boyer, Laurie Ann Failure of the human heart to maintain sufficient output of blood for the demands of the body, heart failure, is a common condition with high mortality even with modern therapeutic alternatives. To identify molecular determinants of mortality in patients with new-onset heart failure, we performed a meta-analysis of genome-wide association studies and follow-up genotyping in independent populations. We identified and replicated an association for a genetic variant on chromosome 5q22 with 36% increased risk of death in subjects with heart failure (rs9885413, P = 2.7x10⁻⁹. We provide evidence from reporter gene assays, computational predictions and epigenomic marks that this polymorphism increases activity of an enhancer region active in multiple human tissues. The polymorphism was further reproducibly associated with a DNA methylation signature in whole blood (P = 4.5x10⁻⁴⁰) that also associated with allergic sensitization and expression in blood of the cytokine TSLP (P = 1.1x10⁻⁴). Knockdown of the transcription factor predicted to bind the enhancer region (NHLH1) in a human cell line (HEK293) expressing NHLH1 resulted in lower TSLP expression. In addition, we observed evidence of recent positive selection acting on the risk allele in populations of African descent. Our findings provide novel genetic leads to factors that influence mortality in patients with heart failure. National Heart, Lung, and Blood Institute (HHSN268201100005C) National Heart, Lung, and Blood Institute (HHSN268201100006C) National Heart, Lung, and Blood Institute (HHSN268201100007C) National Heart, Lung, and Blood Institute (HHSN268201100008C) National Heart, Lung, and Blood Institute (HHSN268201100009C) National Heart, Lung, and Blood Institute (HHSN268201100010C) National Heart, Lung, and Blood Institute (HHSN268201100011C) National Heart, Lung, and Blood Institute (HHSN268201100012C) National Heart, Lung, and Blood Institute (N01-HC-55015) National Heart, Lung, and Blood Institute (N01-HC-55016) National Heart, Lung, and Blood Institute (N01-HC-55018) National Heart, Lung, and Blood Institute (N01-HC-55019) National Heart, Lung, and Blood Institute (N01-HC-55020) National Heart, Lung, and Blood Institute (N01-HC-55021) National Heart, Lung, and Blood Institute (N01-HC-55022) National Heart, Lung, and Blood Institute (R01HL087641) National Heart, Lung, and Blood Institute (R01HL59367) National Heart, Lung, and Blood Institute (R01HL086694) National Human Genome Research Institute (U.S.) (U01HG004402) United States. National Institutes of Health (HHSN268200625226C) United States. National Institutes of Health (UL1RR025005) National Heart, Lung, and Blood Institute (HHSN268201200036C) National Heart, Lung, and Blood Institute (N01HC55222) National Heart, Lung, and Blood Institute (HHSN268200800007C) National Heart, Lung, and Blood Institute (N01HC85079) National Heart, Lung, and Blood Institute (N01HC85080) National Heart, Lung, and Blood Institute (N01HC85081) National Heart, Lung, and Blood Institute (N01HC85082) National Heart, Lung, and Blood Institute (N01HC85083) National Heart, Lung, and Blood Institute (N01HC85086) National Heart, Lung, and Blood Institute (U01HL080295) National Science Foundation (U.S.) (R01HL087652) National Heart, Lung, and Blood Institute (R01HL105756) National Heart, Lung, and Blood Institute (R01HL103612) National Heart, Lung, and Blood Institute (R01HL120393) National Institute on Aging (R01AG023629) National Center for Advancing Translational Sciences (U.S.) (UL1TR000124) National Institute of Diabetes and Digestive and Kidney Diseases (U.S.) (DK063491) National Heart, Lung, and Blood Institute (N01-HC-25195) National Heart, Lung, and Blood Institute (2K24HL04334) National Heart, Lung, and Blood Institute (R01HL077477) National Heart, Lung, and Blood Institute (R01HL093328) National Heart, Lung, and Blood Institute (NIH R01HL105993) National Institute on Aging (N01AG62101) National Heart, Lung, and Blood Institute (N01AG62103) National Heart, Lung, and Blood Institute (N01AG62106) National Institute on Aging (1R01AG032098-01A1) United States. National Institutes of Health (HHSN268200782096C) National Cancer Institute (U.S.) (CA-34944) National Cancer Institute (U.S.) (CA-40360) National Cancer Institute (U.S.) (CA-097193) National Heart, Lung, and Blood Institute (HL-26490) National Heart, Lung, and Blood Institute (HL-34595) 2017-04-13T17:20:12Z 2017-04-13T17:20:12Z 2016-05 2015-09 Article http://purl.org/eprint/type/JournalArticle 1553-7404 1553-7390 http://hdl.handle.net/1721.1/108114 Smith, J. Gustav; Felix, Janine F.; Morrison, Alanna C.; Kalogeropoulos, Andreas; Trompet, Stella; Wilk, Jemma B.; Gidlöf, Olof; et al. “Discovery of Genetic Variation on Chromosome 5q22 Associated with Mortality in Heart Failure.” Edited by Samuli Ripatti. PLOS Genetics 12, no. 5 (May 5, 2016): e1006034. https://orcid.org/0000-0003-3491-4962 en_US http://dx.doi.org/10.1371/journal.pgen.1006034 PLOS Genetics CC0 1.0 Universal https://creativecommons.org/publicdomain/zero/1.0/ application/pdf Public Library of Science PLOS
spellingShingle Wang, Xinchen
Kellis, Manolis
Boyer, Laurie Ann
Discovery of Genetic Variation on Chromosome 5q22 Associated with Mortality in Heart Failure
title Discovery of Genetic Variation on Chromosome 5q22 Associated with Mortality in Heart Failure
title_full Discovery of Genetic Variation on Chromosome 5q22 Associated with Mortality in Heart Failure
title_fullStr Discovery of Genetic Variation on Chromosome 5q22 Associated with Mortality in Heart Failure
title_full_unstemmed Discovery of Genetic Variation on Chromosome 5q22 Associated with Mortality in Heart Failure
title_short Discovery of Genetic Variation on Chromosome 5q22 Associated with Mortality in Heart Failure
title_sort discovery of genetic variation on chromosome 5q22 associated with mortality in heart failure
url http://hdl.handle.net/1721.1/108114
https://orcid.org/0000-0003-3491-4962
work_keys_str_mv AT wangxinchen discoveryofgeneticvariationonchromosome5q22associatedwithmortalityinheartfailure
AT kellismanolis discoveryofgeneticvariationonchromosome5q22associatedwithmortalityinheartfailure
AT boyerlaurieann discoveryofgeneticvariationonchromosome5q22associatedwithmortalityinheartfailure